Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 5/20 | 0.64 |
| ▸ | TERT | O14746 | 2/20 | 0.57 |
| ▸ | DTYMK | P23919 | 4/20 | 0.56 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.49 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.49 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.44 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26189524 | 1.00 | F2 (0.64) | F2TERTDTYMKP2RY2P2RY4 | |
| SCHEMBL21504636 | 1.00 | F2 (0.64) | F2TERTDTYMKP2RY2P2RY4 | |
| SCHEMBL26189527 | 1.00 | F2 (0.64) | F2TERTDTYMKP2RY2P2RY4 | |
| SCHEMBL21489391 | 0.97 | F2 (0.60) | F2TERTDTYMKP2RY2P2RY4 | |
| SCHEMBL29501178 | 0.97 | F2 (0.60) | F2TERTDTYMKP2RY2P2RY4 | |
| SCHEMBL30639044 | 0.97 | F2 (0.60) | F2TERTDTYMKP2RY2P2RY4 | |
| SCHEMBL29624021 | 0.97 | F2 (0.60) | F2TERTDTYMKP2RY2P2RY4 | |
| SCHEMBL14389886 | 0.96 | DTYMK (0.60) | F2TERTDTYMKP2RY2P2RY4 | |
| SCHEMBL29368960 | 0.96 | DTYMK (0.60) | F2TERTDTYMKP2RY2P2RY4 | |
| SCHEMBL14389953 | 0.96 | DTYMK (0.60) | F2TERTDTYMKP2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11613554-B2 | Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-03-28 | — | — | US | disclosed |
| US-20190322694-A1 | NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS | THE SCRIPPS RESEARCH INSTITUTE | 2019-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11613554-B2 | Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds | PPIP5K2, INPP5B, PTMS | F2 1434/4885TERT 3467/4885DTYMK 988/4885 |
| US-20190322694-A1 | NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS | PPIP5K2, INPP5B, PTMS | F2 1824/4885TERT 3963/4885DTYMK 1110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.